- Adj EPS: $7.20 (Est. $7.29) ❌
- Revenue: $109.6B (Est. $111.5B) ❌; UP +9.8% YoY
- Earnings from Operations: $9.1B; UP +15.2% YoY
- Net Margin: 5.7% (Prev. -1.4% YoY)
- Medical Care Ratio: 84.8% (Prev. 84.3% YoY)
- Operating Cost Ratio: 12.4% (Prev. 14.1% YoY)
- Days Claims Payable: 45.5 (Prev. 47.1 YoY)
- Cash Flows from Operations: $5.5B
- Returned nearly $5B to shareholders via dividends and share repurchases
- Return on Equity: 26.8%
FY25 Guidance (Revised):
- Adj EPS: $26.00–$26.50 (Prev. $29.50–$30.00) ❌
Q1 Segment Performance:
UnitedHealthcare
- Revenue: $84.6B; UP +$9.3B YoY
- Operating Earnings: $5.2B (vs. $4.4B YoY)
- Operating Margin: 6.2% (vs. 5.8% YoY)
- Members Served (YTD): +780,000
- Growth in Senior & Complex Care Members: +545,000 in Q1
- Self-Funded Commercial Members: +700,000
- Medicaid Membership: 7.6M
Optum
- Revenue: $63.9B (Est. 67B)
- Operating Margin: 6.1% (vs. 5.8% YoY)
Optum Health
- Revenue: $25.3B
- Targeting +650,000 new value-based care patients in 2025
Optum Insight
- Revenue: $4.6B
- Backlog: $32.9B
- Launched AI-powered claims tools with 20%+ productivity gains
Optum Rx
- Revenue: $35.1B
- Adjusted Scripts: 408M (vs. 395M YoY)
Company Commentary:
- "Performance did not meet expectations; aggressively addressing challenges to return to long-term EPS growth target of 13–16%." – CEO Andrew Witty
- Heightened care activity and changes in Medicare Advantage member profiles drove the downward revision in outlook
- Still expects 650,000 new value-based care patients in Optum Health for FY25
